New guidance on AI in publishing; ChatGPT in medicine; pig organs in humans
October 19, 2023
Editors Issue Guidance on Use of AI in Scholarly Publishing Firm ban on chatbots as authors--but allowing AI-generated text and illustrations
Editors at seven scholarly bioethics and humanities journals published recommendations on the responsible use of generative artificial intelligence tools by authors, reviewers, and editors. The recommendations take a firm stand against regarding generative AI as an author – but allow the use of the technology to generate text and illustrations. “These constraints are needed in part to protect high-quality scholarship, as other statements have noted, but they are also vital for wider social reasons,” said Gregory E. Kaebnick, lead author of the recommendations and editor of the Hastings Center Report. Read the statement.
Examining ChatGPT's New Ethical Implications for Medical AI "Swiss Army Knife of AI" raises three ethical concerns
Generative AI, including ChatGPT, is largely capable of action beyond narrow tasks like medical diagnosis, but its general design -- “the Swiss Army Knife of AI” --is novel within health care, thereby introducing several new bioethical challenges, write Hastings Center President Vardit Ravitsky and coauthors in the American Journal of Bioethics. They highlight three key ethical concerns: transparency, trust, and responsibility. “If, for instance, ChatGPT provides medical advice that results in a fatality, who should shoulder the blame and be accountable?” Read the AJOB article.
Pig Organs in Humans: Ethical and Policy Issues Podcast surveys the landscape
Each day, 17 people in the United States on the organ transplant waiting list die while waiting for an organ, a figure that Hastings Center senior research scholar Karen Maschke used to underscore the consequences of the shortage of human organs for transplant and the hope raised by the prospect of using pig organs, or xenotransplantation. In the On Tech Ethics Podcast, Maschke discussed xenotransplantation, including the ethical and policy considerations of xenotransplant clinical trials. Listen to the podcast.
The Hastings Center seeks to ensure responsible health and science policy and practice. We work to secure the wisest possible use of emerging technologies and fair, compassionate, and just health care for people across their lifespan.
We strongly value your privacy and would never sell, give, or otherwise share your information. Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.
